SEC Form 4 · accession 0001209191-19-001326
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Gray
Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 3, 2019 · 6:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645460
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $5.16 | Jan 2, 2019 | A | 8,000 | A | Jan 2, 2020 | Jan 2, 2026 | Common Stock | 8,000 | 8,000 | D |